IL238288B - Pyrazolopyridazines and their use in the treatment of diseases of retinal degeneration and hearing loss associated with Asher syndrome - Google Patents

Pyrazolopyridazines and their use in the treatment of diseases of retinal degeneration and hearing loss associated with Asher syndrome

Info

Publication number
IL238288B
IL238288B IL238288A IL23828815A IL238288B IL 238288 B IL238288 B IL 238288B IL 238288 A IL238288 A IL 238288A IL 23828815 A IL23828815 A IL 23828815A IL 238288 B IL238288 B IL 238288B
Authority
IL
Israel
Prior art keywords
pyrazolopyridazines
hearing loss
degenerative diseases
loss associated
usher syndrome
Prior art date
Application number
IL238288A
Other languages
English (en)
Hebrew (he)
Other versions
IL238288A0 (en
Original Assignee
Usher Iii Initiative Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Usher Iii Initiative Inc filed Critical Usher Iii Initiative Inc
Publication of IL238288A0 publication Critical patent/IL238288A0/en
Publication of IL238288B publication Critical patent/IL238288B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL238288A 2012-10-25 2015-04-14 Pyrazolopyridazines and their use in the treatment of diseases of retinal degeneration and hearing loss associated with Asher syndrome IL238288B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261718611P 2012-10-25 2012-10-25
US201361775402P 2013-03-08 2013-03-08
PCT/US2013/066939 WO2014066836A1 (en) 2012-10-25 2013-10-25 Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome

Publications (2)

Publication Number Publication Date
IL238288A0 IL238288A0 (en) 2015-06-30
IL238288B true IL238288B (en) 2018-04-30

Family

ID=50545356

Family Applications (1)

Application Number Title Priority Date Filing Date
IL238288A IL238288B (en) 2012-10-25 2015-04-14 Pyrazolopyridazines and their use in the treatment of diseases of retinal degeneration and hearing loss associated with Asher syndrome

Country Status (10)

Country Link
EP (1) EP2911671B1 (enExample)
JP (1) JP6291502B2 (enExample)
AU (1) AU2013334139B2 (enExample)
CA (1) CA2889494C (enExample)
ES (1) ES2687854T3 (enExample)
HU (1) HUE039970T2 (enExample)
IL (1) IL238288B (enExample)
PL (1) PL2911671T3 (enExample)
WO (1) WO2014066836A1 (enExample)
ZA (1) ZA201502655B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2834049C (en) 2011-04-25 2018-05-22 Usher Iii Initiative, Inc. Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
US9227976B2 (en) 2012-10-25 2016-01-05 Usher Iii Initiative, Inc. Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
PL2912038T3 (pl) * 2012-10-25 2019-02-28 Usher Iii Initiative, Inc. Pirazolopirydazyny oraz sposoby leczenia zwyrodnieniowych chorób siatkówki i utraty słuchu związanych z zespołem ushera
WO2017045955A1 (en) * 2015-09-14 2017-03-23 Basf Se Heterobicyclic compounds
KR20200033249A (ko) 2017-06-05 2020-03-27 피티씨 테라퓨틱스, 인크. 헌팅턴병 치료 화합물
US12103926B2 (en) 2018-03-27 2024-10-01 Ptc Therapeutics, Inc. Compounds for treating huntington's disease
AU2019294478B2 (en) 2018-06-27 2023-03-23 Ptc Therapeutics, Inc. Heterocyclic and heteroaryl compounds for treating Huntington's disease
WO2020005877A1 (en) 2018-06-27 2020-01-02 Ptc Therapeutics, Inc. Heteroaryl compounds for treating huntington's disease
WO2020161209A1 (en) 2019-02-06 2020-08-13 Syngenta Crop Protection Ag Herbicidal fused pyridazine compounds
WO2020161208A1 (en) 2019-02-06 2020-08-13 Syngenta Crop Protection Ag Herbicidal fused pyridazine compounds
EP4466264A1 (en) * 2022-01-19 2024-11-27 Institut National de la Santé et de la Recherche Médicale (INSERM) Geralexin and uses thereof for the treatment of retinal degenerative diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0206723D0 (en) * 2002-03-21 2002-05-01 Glaxo Group Ltd Novel compounds
US20090306045A1 (en) * 2005-12-22 2009-12-10 Ira Mellman Inhibition of Glycogen Synthase Kinase and Methods of Treating Autoimmune or Immune Inflammatory Disease
JP2011503103A (ja) * 2007-11-07 2011-01-27 フォールドアールエックス ファーマシューティカルズ インコーポレーティッド タンパク質輸送の調節方法
CA2834049C (en) * 2011-04-25 2018-05-22 Usher Iii Initiative, Inc. Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
PL2912038T3 (pl) * 2012-10-25 2019-02-28 Usher Iii Initiative, Inc. Pirazolopirydazyny oraz sposoby leczenia zwyrodnieniowych chorób siatkówki i utraty słuchu związanych z zespołem ushera

Also Published As

Publication number Publication date
AU2013334139A1 (en) 2015-04-30
WO2014066836A1 (en) 2014-05-01
AU2013334139B2 (en) 2017-08-03
EP2911671B1 (en) 2018-06-27
ZA201502655B (en) 2017-11-29
EP2911671A1 (en) 2015-09-02
EP2911671A4 (en) 2016-09-14
HK1214180A1 (en) 2016-07-22
CA2889494A1 (en) 2014-05-01
IL238288A0 (en) 2015-06-30
ES2687854T3 (es) 2018-10-29
JP2015535257A (ja) 2015-12-10
JP6291502B2 (ja) 2018-03-14
HUE039970T2 (hu) 2019-02-28
PL2911671T3 (pl) 2018-11-30
CA2889494C (en) 2018-12-18

Similar Documents

Publication Publication Date Title
IL238288B (en) Pyrazolopyridazines and their use in the treatment of diseases of retinal degeneration and hearing loss associated with Asher syndrome
ZA201507790B (en) Enhanced adoptive cell therapy
IL234628A0 (en) Imidazolyl-pyrimidines are converted into amino-indolyl and their use as drugs
IL235826A0 (en) Diazaspirocycloalkane and azaspirocycloalkane
EP2828258A4 (en) NOVEL PYRIDOPYRIMIDINE DERIVATIVES AND THEIR USE
ZA201307961B (en) Pyrazolopyridazines and methods for treating retinal-degenarative diseases and hearing loss associated with usher syndrome
EP2839816A4 (en) LAYER UNIT AND EXTERNAL LAYER ENVELOPE
EP2907494A4 (en) TABLE FOR WHEELCHAIR AND WHEELCHAIR COMPRISING THE SAME
SG11201405418WA (en) Absorbent and absorbent article provided therewith
ZA201504405B (en) 6-chloro-3-(phenyl-d5)-inden-1-one and use thereof
ZA201405392B (en) Substituted phenylimidazopyrazoles and use thereof
GB2508663B (en) Bedpan and bedpan support
GB2504303B (en) Earphones and earplugs
GB201213782D0 (en) Process and dressing
ZA201502654B (en) Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
GB201213778D0 (en) Process and dressng
GB201221092D0 (en) Assemblies and methods
IL243842A0 (en) Hydrogel fibers and methods for their preparation
AU2012901222A0 (en) Treatment and prophylaxis
GB201222541D0 (en) Kiddibidet and pottibidet
IL218974A0 (en) Conaction bitwen coutch and playels
GB201202021D0 (en) Co-sleeper and breastfeeder
ME03635B (me) 6-hlor0-3-(fenil-d5)-inden-1-on i njegova upotreba
GB201211961D0 (en) Methods and groups
GB201208845D0 (en) Methods and groups

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed